We are live on ! Find out more
KXA

KPCB XIII Associates Portfolio holdings

AUM $186M
1-Year Est. Return 11.23%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-11.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$226M
AUM Growth
+$16.1M
Cap. Flow
+$30.6M
Cap. Flow %
13.52%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MVLA
Movella Holdings Inc. Common Stock
MVLA
+$30.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 96.88%
2 Technology 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGNY icon
1
Progyny
PGNY
$2.4B
$208M 91.96%
6,473,515
LUNG icon
2
Pulmonx
LUNG
$51.5M
$11.1M 4.92%
994,971
MVLA
3
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$7.06M 3.12%
+5,189,011
New +$30.6M

Similar funds

KPCB XIII Associates's Q1 2023 Portfolio in Review

As of Q1 2023, KPCB XIII Associates held 3 positions worth $226M, up 7.7% from $210M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XIII Associates deployed $30.6M of net new capital in Q1 2023, opening 1 new position. Its largest new stake was Movella Holdings Inc. Common Stock: 5,189,011 shares worth $7.06M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 100% a quarter earlier, followed by Technology.

  • KPCB XIII Associates's largest Q1 2023 buy was Movella Holdings Inc. Common Stock: 5,189,011 shares worth $7.06M.
  • KPCB XIII Associates's ten largest holdings make up 100% of its $226M portfolio in Q1 2023.
  • KPCB XIII Associates opened 1 new position and closed 0 in Q1 2023.
  • KPCB XIII Associates's portfolio value rose 7.7% quarter-over-quarter to $226M.

Based on KPCB XIII Associates's 13F filing for Q1 2023, filed 12 May 2023.